Catalyst Wire Dossier Catalyst Wire Dossier

Caplyta

lumateperone · Intra-Cellular Therapies, Inc.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Caplyta, covering 2019-12-20 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Caplyta in Borderline Personality Disorder [Phase 2]

See pricing